Key result
KCNJ11 E23K polymorphism linked to ~12% greater T2D risk per allele.
Why the study?
Does the KCNJ11 E23K polymorphism increase the risk of type 2 diabetes?
Meta-Analysis (n=139,598)
Does the KCNJ11 E23K polymorphism increase the risk of type 2 diabetes?
The KCNJ11 E23K polymorphism is associated with a modest but statistically significant increased risk of type 2 diabetes, particularly in Caucasian and East Asian populations.
Answers are grounded in this paper and cite their sources.
No immediate change to T2D risk assessment; confirms association but leaves clinical utility open.
To clarify the role of potassium inwardly-rectifying-channel, subfamily-J, member 11 (KCNJ11) variation in susceptibility to type 2 diabetes (T2D), we performed a systematic meta-analysis to investigate the association between the KCNJ11 E23K polymorphism (rs5219) and the T2D in different genetic models. Databases including PubMed, Medline, EMBASE, and ISI Web of Science were searched to identify relevant studies. A total of 48 published studies involving 56,349 T2D cases, 81,800 controls, and 483 family trios were included in this meta-analysis. Overall, the E23K polymorphism was significantly associated with increased T2D risk with per-allele odds ratio (OR) of 1.12 (95% CI: 1.09-1.16; P<10-5). The summary OR for T2D was 1.09 (95% CI: 1.03-1.14; P<10-5), and 1.26 (95% CI: 1.17-1.35; P<10-5), for heterozygous and homozygous, respectively. Similar results were also detected under dominant and recessive genetic models. When stratified by ethnicity, significantly increased risks were found for the polymorphism in Caucasians and East Asians. However, no such associations were detected among Indian and other ethnic populations. Significant associations were also observed in the stratified analyses according to different mean BMI of cases and sample size. Although significant between study heterogeneity was identified, meta-regression analysis suggested that the BMI of controls significantly correlated with the magnitude of the genetic effect. The current meta-analysis demonstrated that a modest but statistically significant effect of the 23K allele of rs5219 polymorphism in susceptibility to T2D. But the contribution of its genetic variants to the epidemic of T2D in Indian and other ethnic populations appears to be relatively low.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2014) conducted a meta-analysis in Type 2 Diabetes (n=139,598). KCNJ11 E23K polymorphism (rs5219) vs. Wild type / non-carriers (E allele) was evaluated on Type 2 diabetes risk (per-allele) (OR 1.12, 95% CI 1.09-1.16, p=<10^-25). The KCNJ11 E23K polymorphism was significantly associated with an increased risk of type 2 diabetes, with a per-allele odds ratio of 1.12.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: